4893 Noile-Immune Biotech
- 170
- +11+6.92%
Noile-Immune Biotech News
Noil Immune Biotech --- Selection of loan stocks in the Tokyo Stock Exchange Growth Market.
Noil Immune Biotech <4893> announced on the 20th that it has been selected as a borrowable stock in the Tokyo Stock Exchange's Growth Market. The company is an academia-origin biotech firm working on the practical application of next-generation cancer immunotherapy for solid tumors using its unique innovative technology, "PRIME technology," which enhances the therapeutic effects of immune cell therapy through PRIME CAR-T cells. The selection date is December 23, 2024 (Monday), and the implementation will start from the trading of that day.
Noil Immune, True Data, among others.
Revised financial estimates: forecasted consolidated ordinary profit for the first half is 0.013 billion yen, down from 0.027 billion yen, and the full-year consolidated ordinary profit forecast is 0.101 billion yen, down from 0.136 billion yen.
Noile-Immune Biotech: Notice regarding publication of earnings forecasts
Noile-Immune Biotech: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Asahi, Matsukiyo, Dentsu Group, Lancers (14th) (1379-4990)
※The above calendar is merely a schedule and may be subject to change due to the company's circumstances. --------------------------------------- November 14 (Thursday) <1379> Hokuto <1380> Akikawa Bokuen <142A> Jinjibu <1438> Gifu Landscape <1443> Giken HD <1446> Candiule <1447> SAAF HD <145A> El
Volume change rate ranking (10:00 am) - NEC, KIMOTO, etc. are ranked.
In the volume change rate ranking, you can understand the interests of market participants such as trends in trading by comparing the average volume of the past 5 days with the volume on the delivery day. ■ Top volume change rate [10:32 on October 30] (comparison of average volume of the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate ＜7908＞KIMOTO 59854 0118 210.44 282% 0.2663% ＜4893＞NOI
Noile-Immune Biotech: Correction Confirmation Form
Noile-Immune Biotech: Revised Semi-Annual Report - Term 10 (2024/01/01 to 2024/12/31)
Emerging markets outlook: Interested in confirming the increase in trading volume in growth markets.
Interest in main stocks did not increase, and trading volume stunk this week in emerging markets. During the same period, while the Nikkei Average fell by -3.00%, the Growth Market Index fell by -3.69% and the Growth Market 250 Index fell by -4.22%. Similar to the Prime Market, there was a rollback of 'high market trading' at the beginning of the week, leading to a decline. Subsequently, influenced by the words and actions of the newly appointed Prime Minister Ishiba, buying in main stocks was held back, and short-term funds flowed into recent IPO stocks, among other reasons.
Stocks that moved the previous day part 2: Ikuyo, Tasukawa Electricity, QPS Research Institute, etc.
Stock Name <Code> 26th closing price⇒Compared to the previous day, deere & co Life <3245> 860 -36 Due to the ex-dividend rights fall at the end of the month, Round One <4680> 1050 -33 The impact of the dividend and preferential rights fall is predominant. Petroleum Resource Development <1662> 1060 -30 Due to the decline in crude oil prices following the production increase report. JVC Kenwood <6632> 1358 -61 Also, profit-taking sales are gathering in a scenario in the high price range. ENEOS <5020> 787.6 -19.0 To offset the decline in crude oil prices.
The TOPIX Growth Market 250 index rose significantly, showing strong movement with trading volume not seen in two and a half months.
Tokyo Stock Exchange Growth Market Index 859.07 +16.46 / Volume 0.1 billion 73.82 million shares / Trading value 172.9 billion yen. Tokyo Stock Exchange Growth Market 250 Index 675.75 +14.10 / Volume 0.1 billion 37.99 million shares / Trading value 142.4 billion yen. Today's growth market sees significant gains in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. The number of advancing stocks is 347, declining stocks are 196, unchanged at 4126. The U.S. stock market rose on the 260.36 dollar Dow average day.
Active and newly listed stocks during the morning session.
*Toho Zinc <5707> 1070 +91, optimistic about the lithium-ion battery recycling business. *Japan Micronics <6871> 4320 +340, continues to ride the wave of high semiconductor-related stocks. *Reed's Inc <4612> 1051 +61.3, continues to attract attention as a China-related company. *Shiseido Company,Limited Sponsored ADR <4911> 3995 +210, investment rating upgraded by Jefferies Securities. *Hamamatsu Photonics <6965> 1864.5 +99.5, a player in the field of nuclear fusion-related.
Volume change rate ranking (10 o'clock) - Melco, Bushiroad, etc. are ranked.
※In the volume change rate ranking, you can understand the interest of market participants, such as trends in trading, by comparing the average volume of the past 5 days with the volume on the delivery day. ■Top volume change rate [As of 10:32 on September 27] (Comparison with average volume of the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Price change rate ＜1487＞ U.S. Treasury HE 22624 51212.14 225.98% 0%
Stocks that moved the previous day part1: J-Oil, Will Group, Extreme, etc.
Stock Name <Code> 26th closing price ⇒ Previous day comparison * J-Oil <2613> 2115 +127: Financial estimates for the fiscal year ending March 2025 revised upward, commemorative dividend implemented. * Will Group <6089> 1006 +67: Financial estimates for the first half of the fiscal year ending March 2025 revised upward. * NaITO <7624> 136 -102: Performance forecast for the fiscal year ending February 2025 revised downward. * Extreme <6033> 1142 +58: Global cumulative sales of "Lollipop Chainsaw RePOP" exceed 0.1 million units. * Noise
Active and newly established stocks in the afternoon session.
*J-Oil <2613> 2115 +127 Financial estimates for the fiscal year ending March 2025 have been revised upward, and a special dividend will be implemented. *Will Group <6089> 1006 +67 Financial estimates for the first half of the fiscal year ending March 2025 have been revised upward. *NaITO <7624> 136 -10 Financial estimates for the fiscal year ending February 2025 have been revised downward. *Extreme <6033> 1142 +58 The worldwide cumulative sales of 'Lollipop Chainsaw RePOP' have exceeded 0.1 million units. *Noile Immune <4893> 191
Emerging markets stock digest: Extreme continues to rise significantly, while Noil Immune rebounds sharply.
<6033> Extreme 1142 +58 significantly extends gains. It was announced that the total worldwide sales of 'Lollipop Chainsaw RePOP,' a zombie action game by the group company Dragami Games (include package version shipments and download version sales), have surpassed 0.1 million copies in the first week since its release, leading to buying interest. The game supports English, Japanese, Traditional Chinese, French, Italian, German, Spanish, Latin American Spanish, and Brazilian.
Hot stocks digest (morning session): Sanwa HD, Japan oracle corp, Noil immune, etc
Air Clo <9557>: 375 yen (+10 yen) rebounded. After the close of trading on the 25th, it was announced that the business of re-commercializing damaged goods of United Arrows has begun. The outsourcing of this re-commercialization business of damaged goods is a case of "individual customization", where United Arrows, in promoting the sustainability activity "SARROWS", has been strengthening the "re-commercialization of B products" that it has been working on, introducing a circular platform, and starting collaboration with the company.
Volume change rate ranking (as of 10:00) - J Oil, Asentec, etc. are ranked.
*In the volume change rate ranking, you can understand the interests of market participants such as trends in searching by comparing the average volume of the past 5 days with the volume on the delivery day. *Top volume change rate [as of September 26, 10:32] (comparison with average volume of the past 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <3565> Asentec 631,900 59,332.36 204.27% 0.079
Noile Immun --- rapid rebound, signed a business alliance contract with Takara Bio on the development of NIB103.
Sharp rebound. Takeda Bio and NIB103, their own PRIME CAR-T cells using cancer patients' own lymphocytes, have signed a business partnership agreement for the development.
September 26th [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stocks] Asentec <3565> 581 yen (9/25) Engaged in product development related to virtual desktops. Announced a capital business alliance with US CSG, which provides enterprise software solutions. Asentec will allocate 0.7 million shares of common stock to CSG through third-party allotment (holding ratio after third-party allotment increase 5.01%). In order to provide higher quality virtual desktop system construction, engineering resources.
No Data